CIK: 0001300336
Total reported value
$2.6B
Reporting period: 2023-06-30 · Number of holdings: 166
Tekla Capital Management LLC disclosed 166 holdings in its latest 13F filing for the period ending 2023-06-30, with total reported value of $2.6B and a quarterly turnover rate of 0.0%.
Browse other institutions with $1B to $10B AUMBrowse other institutions starting with "T"
No strong tilt toward either adding to existing winners or initiating outsized new positions was observed in the latest reported quarter.
Sector classification currently covers about 0% of this portfolio's disclosed value; the remainder includes holdings (e.g. unmapped tickers, options, or other security types) not yet covered by our sector mapping.
No holding changes this quarter
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | AMGN | Amgen INC | Stock-Healthcare | 5.36% | — | +10.90% | |
| 2 | JNJ | Johnson & Johnson | Stock-Healthcare | 4.68% | — | — | |
| 3 | GILD | Gilead Sciences INC | Stock-Healthcare | 4.63% | — | -1.67% | |
| 4 | REGN | Regeneron Pharmaceuticals | Stock-Healthcare | 4.54% | — | +12.84% | |
| 5 | VRTX | Vertex Pharmaceuticals INC | Stock-Healthcare | 4.38% | — | -3.72% | |
| 6 | LLY | Eli Lilly & Co | Stock-Healthcare | 3.92% | — | -26.15% | |
| 7 | UNH | Unitedhealth Group INC | Stock-Healthcare | 3.89% | — | -11.62% | |
| 8 | MRK | Merck & Co. INC. | Stock-Healthcare | 3.29% | — | +31.88% | |
| 9 | ABBV | Abbvie INC | Stock-Healthcare | 2.88% | — | +6.65% | |
| 10 | BIIB | Biogen INC | Stock-Healthcare | 2.76% | — | +2.91% | |
| 11 | AZNN | Astrazeneca Plc-spons Adr | Stock-Other | 2.74% | — | -1.61% | |
| 12 | ILMN | Illumina INC | Stock-Healthcare | 2.47% | — | -3.19% | |
| 13 | ABT | Abbott Laboratories | Stock-Healthcare | 2.36% | — | -11.45% | |
| 14 | PFE | Pfizer INC | Stock-Healthcare | 2.33% | — | -8.48% | |
| 15 | TMO | Thermo Fisher Scientific INC | Stock-Healthcare | 2.02% | — | +5.64% | |
| 16 | ELV | Elevance Health INC | Stock-Healthcare | 1.98% | — | — | |
| 17 | MRNA | Moderna INC | Stock-Healthcare | 1.63% | — | +6.67% | |
| 18 | BSX | Boston Scientific CORP | Stock-Healthcare | 1.39% | — | +16.22% | |
| 19 | DHR | Danaher CORP | Stock-Healthcare | 1.34% | — | +35.12% | |
| 20 | MDT | Medtronic plc | Stock-Healthcare | 1.19% | — | -0.03% | |
| 21 | IDXX | Idexx Laboratories INC | Stock-Healthcare | 1.15% | — | — | |
| 22 | DXCM | Dexcom INC | Stock-Healthcare | 1.15% | — | — | |
| 23 | BMY | Bristol-myers Squibb Co | Stock-Healthcare | 1.15% | — | -30.93% | |
| 24 | ISRG | Intuitive Surgical INC | Stock-Healthcare | 1.12% | — | -25.47% | |
| 25 | ALNY | Alnylam Pharmaceuticals INC | Stock-Healthcare | 1.06% | — | — | |
| 26 | CI | THE Cigna Group | Stock-Healthcare | 1.06% | — | -47.25% | |
| 27 | MCK | Mckesson CORP | Stock-Healthcare | 1.04% | — | -6.77% | |
| 28 | ARGX | Argenx Se - Adr | Stock-Healthcare | 1.00% | — | -25.77% | |
| 29 | HCA | Hca Healthcare INC | Stock-Healthcare | 0.98% | — | -7.10% | |
| 30 | SYK | Stryker CORP | Stock-Healthcare | 0.97% | — | +13.34% | |
| 31 | IQV | Iqvia Holdings INC | Stock-Healthcare | 0.96% | — | +72.90% | |
| 32 | ZTS | Zoetis INC | Stock-Healthcare | 0.92% | — | — | |
| 33 | CRL | Charles River Laboratories | Stock-Healthcare | 0.91% | — | -5.84% | |
| 34 | SGENUSD | Seagen INC | Stock-Other | 0.85% | — | -50.00% | |
| 35 | SRPT | Sarepta Therapeutics INC | Stock-Healthcare | 0.80% | — | -37.18% | |
| 36 | NVO | Novo-nordisk A/s-spons Adr | Stock-Healthcare | 0.78% | — | +10.29% | |
| 37 | ✓ | Oculis Holding AG | Stock-Other | 0.74% | — | — | |
| 38 | MOH | Molina Healthcare INC | Stock-Healthcare | 0.73% | — | — | |
| 39 | JAZZ | Jazz Pharmaceuticals plc | Stock-Healthcare | 0.72% | — | — | |
| 40 | BMRN | Biomarin Pharmaceutical INC | Stock-Healthcare | 0.72% | — | -29.76% | |
| 41 | EW | Edwards Lifesciences CORP | Stock-Healthcare | 0.70% | — | +10.78% | |
| 42 | HUM | Humana INC | Stock-Healthcare | 0.64% | — | — | |
| 43 | APLSUSD | Apellis Pharmaceuticals INC | Stock-Other | 0.62% | — | +28.21% | |
| 44 | BAX | Baxter International INC | Stock-Healthcare | 0.58% | — | +381.89% | |
| 45 | EXEL | Exelixis INC | Stock-Healthcare | 0.54% | — | — | |
| 46 | NVS | Novartis Ag-sponsored Adr | Stock-Healthcare | 0.54% | — | — | |
| 47 | ✓ | Stock-Other | 0.50% | — | +9.59% | ||
| 48 | PODD | Insulet CORP | Stock-Healthcare | 0.49% | — | — | |
| 49 | GH | Guardant Health INC | Stock-Healthcare | 0.48% | — | -26.71% | |
| 50 | ASND | Ascendis Pharma A/S | Stock-Other | 0.48% | — | +12.12% |
Performance for Q3 2026
+10.3%
Performance Last 4 Quarters
+25.7%
Based on 60% of reported portfolio value with available pricing
| Period | Holdings | Total value | Stability | Top holdings |
|---|---|---|---|---|
| 2023-06-30 | 166 | $2.6B | 0 | |
| 2023-03-31 | 177 | $2.6B | 0 | |
| 2022-12-31 | 172 | $2.6B | 0 | |
| 2022-09-30 | 169 | $2.4B | 0 | |
| 2022-06-30 | 177 | $2.5B | 0 | |
| 2022-03-31 | 175 | $2.8B | 0 | |
| 2021-12-31 | 171 | $3.1B | 0 | |
| 2021-09-30 | 172 | $3.1B | 0 | |
| 2021-06-30 | 189 | $3.1B | 97 | |
| 2021-03-31 | 196 | $2.9B | 34 | |
| 2020-12-31 | 200 | $2.8B | 44 | |
| 2020-09-30 | 204 | $2.7B | 31 | |
| 2020-06-30 | 222 | $2.6B | 29 | |
| 2020-03-31 | 217 | $2.2B | 28 | |
| 2019-12-31 | 214 | $2.6B | 32 | |
| 2019-09-30 | 192 | $2.3B | 20 | |
| 2019-06-30 | 197 | $2.5B | 14 | |
| 2019-03-31 | 194 | $2.5B | 25 | |
| 2018-12-31 | 203 | $2.3B | 25 | |
| 2018-09-30 | 212 | $2.8B | 23 | |
| 2018-06-30 | 180 | $2.6B | 19 | |
| 2018-03-31 | 187 | $2.6B | 29 | |
| 2017-12-31 | 161 | $2.6B | 28 | |
| 2017-09-30 | 152 | $2.8B | 19 | |
| 2017-06-30 | 144 | $2.7B | 18 | |
| 2017-03-31 | 139 | $2.6B | 25 | |
| 2016-12-31 | 143 | $2.3B | 22 | |
| 2016-09-30 | 142 | $2.6B | 28 | |
| 2016-06-30 | 156 | $2.4B | 25 | |
| 2016-03-31 | 140 | $2.4B | 30 | |
| 2015-12-31 | 134 | $2.8B | 30 | |
| 2015-09-30 | 160 | $2.8B | 38 | |
| 2015-06-30 | 116 | $2.8B | 40 | |
| 2015-03-31 | 116 | $2.5B | 42 | |
| 2014-12-31 | 96 | $2.1B | 30 | |
| 2014-09-30 | 108 | $2.1B | 68 | |
| 2014-06-30 | 64 | $1.1B | 25 | |
| 2014-03-31 | 61 | $1.0B | 25 | |
| 2013-12-31 | 57 | $952.5M | 41 | |
| 2013-09-30 | 63 | $898.8M | 29 | |
| 2013-06-30 | 60 | $735.4M | 0 |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|
| Period | Filed | Type | EDGAR |
|---|---|---|---|
| 2023-06-30 | 2023-08-10 | 13F-HR | View on EDGAR |
| 2023-03-31 | 2023-05-10 | 13F-HR | View on EDGAR |
| 2022-12-31 | 2023-02-10 | 13F-HR | View on EDGAR |
| 2022-09-30 | 2022-11-01 | 13F-HR | View on EDGAR |
| 2022-06-30 | 2022-07-29 | 13F-HR | View on EDGAR |
| 2022-03-31 | 2022-05-13 | 13F-HR | View on EDGAR |
| 2021-12-31 | 2022-02-14 | 13F-HR | View on EDGAR |
| 2021-09-30 | 2021-11-12 | 13F-HR | View on EDGAR |
| 2021-06-30 | 2021-08-13 | 13F-HR | View on EDGAR |
| 2021-03-31 | 2021-05-14 | 13F-HR | View on EDGAR |
| 2020-12-31 | 2021-02-12 | 13F-HR | View on EDGAR |
| 2020-09-30 | 2020-11-13 | 13F-HR | View on EDGAR |
| 2020-06-30 | 2020-08-13 | 13F-HR | View on EDGAR |
| 2020-03-31 | 2020-05-14 | 13F-HR | View on EDGAR |
| 2019-12-31 | 2020-02-13 | 13F-HR | View on EDGAR |
| 2019-09-30 | 2019-11-13 | 13F-HR | View on EDGAR |
| 2019-06-30 | 2019-08-14 | 13F-HR | View on EDGAR |
| 2019-03-31 | 2019-05-14 | 13F-HR | View on EDGAR |
| 2018-12-31 | 2019-02-13 | 13F-HR | View on EDGAR |
| 2018-09-30 | 2018-11-13 | 13F-HR | View on EDGAR |
| 2018-06-30 | 2018-08-13 | 13F-HR | View on EDGAR |
| 2018-03-31 | 2018-05-14 | 13F-HR | View on EDGAR |
| 2017-12-31 | 2018-02-14 | 13F-HR | View on EDGAR |
| 2017-09-30 | 2017-11-13 | 13F-HR | View on EDGAR |
| 2017-06-30 | 2017-08-14 | 13F-HR | View on EDGAR |
| 2017-03-31 | 2017-05-12 | 13F-HR | View on EDGAR |
| 2016-12-31 | 2017-02-13 | 13F-HR | View on EDGAR |
| 2016-09-30 | 2016-11-14 | 13F-HR | View on EDGAR |
| 2016-06-30 | 2016-08-12 | 13F-HR | View on EDGAR |
| 2016-03-31 | 2016-05-09 | 13F-HR | View on EDGAR |
| 2015-12-31 | 2016-02-09 | 13F-HR | View on EDGAR |
| 2015-09-30 | 2015-11-13 | 13F-HR | View on EDGAR |
| 2015-06-30 | 2015-08-12 | 13F-HR | View on EDGAR |
| 2015-03-31 | 2015-05-06 | 13F-HR | View on EDGAR |
| 2014-12-31 | 2015-01-30 | 13F-HR | View on EDGAR |
| 2014-09-30 | 2014-11-14 | 13F-HR | View on EDGAR |
| 2014-06-30 | 2014-08-05 | 13F-HR | View on EDGAR |
| 2014-03-31 | 2014-05-13 | 13F-HR | View on EDGAR |
| 2013-12-31 | 2014-01-28 | 13F-HR | View on EDGAR |
| 2013-09-30 | 2013-10-30 | 13F-HR | View on EDGAR |
| 2013-06-30 | 2013-07-31 | 13F-HR | View on EDGAR |
Institutions with a similar AUM
CIK 0001586986
Total reported value
$2.6B
46 stks
2026-03-31
AUM within 0.0% of this institution
CIK 0001870364
Total reported value
$2.6B
574 stks
2026-03-31
AUM within 0.1% of this institution
CIK 0001591122
Total reported value
$2.6B
692 stks
2026-03-31
AUM within 0.2% of this institution
Institutions with overlapping top holdings
CIK 0000019481
Total reported value
$362.5M
450 stks
2026-03-31
4 of the top 5 holdings overlap, including Gilead Sciences INC
CIK 0001642343
Total reported value
$656.3M
127 stks
2015-12-31
Stale — no recent filing
3 of the top 5 holdings overlap, including Gilead Sciences INC
CIK 0001674546
Total reported value
$4.2B
167 stks
2026-03-31
3 of the top 5 holdings overlap, including Vertex Pharmaceuticals INC